Kintor Pharmaceutical Limited
HKEX:9939.HK
1.13 (HKD) • At close November 5, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||
| Net Income
| -1,068.861 | -0.954 | -0.842 | -0.508 | -0.233 | -0.108 | -0.046 | -0.054 | -0.011 | -0.008 |
| Depreciation & Amortization
| 18.976 | 0.018 | 0.01 | 0.006 | 0.005 | 0.002 | 0.001 | 0 | 0 | 0 |
| Deferred Income Tax
| 0 | 0.155 | 0.4 | -0.015 | 0 | 0 | 0 | -0.04 | 0 | 0 |
| Stock Based Compensation
| 22.989 | 95.636 | 37.347 | 28.159 | 0 | 0 | 0 | 0.031 | 0 | 0 |
| Change In Working Capital
| -96.481 | -0.251 | -0.437 | -0.013 | -0.011 | -0.011 | -0.002 | 0.009 | -0.001 | -0 |
| Accounts Receivables
| 0.008 | 0.094 | -0.086 | -0.013 | -0.011 | -0.011 | -0.002 | 0.009 | -0.001 | -0 |
| Inventory
| -0.376 | -0.345 | -0.351 | 0 | 0 | 0 | 0 | -0 | 0 | 0 |
| Accounts Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Working Capital
| 0.003 | 0.03 | -0.006 | -0.007 | -0.016 | -0.005 | 0 | 0 | 0 | 0 |
| Other Non Cash Items
| -3.387 | -0.025 | -0.22 | 0.121 | 0.011 | 0.002 | 0.002 | -0.001 | -0.001 | 0 |
| Operating Cash Flow
| -387.581 | -0.961 | -1.051 | -0.381 | -0.228 | -0.115 | -0.045 | -0.015 | -0.013 | -0.008 |
| Investing Activities: | ||||||||||
| Investments In Property Plant And Equipment
| -2.723 | -0.027 | -0.076 | -0.069 | -0.067 | -0.005 | -0.012 | -0.003 | -0.001 | -0.001 |
| Acquisitions Net
| 0 | -18.513 | -195.534 | 345.179 | -0.578 | 0.577 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| -137.099 | -220.702 | -515.407 | -733.697 | -55 | -221 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 136.251 | 337.057 | 710.941 | 388.518 | 55.578 | 241.482 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 5.216 | -97.747 | 0.168 | -0.371 | 0.06 | -21.118 | -0.016 | 0 | -0.001 | -0.01 |
| Investing Cash Flow
| 3.274 | 0.067 | 0.092 | -0.44 | -0.007 | -0.065 | -0.028 | -0.002 | -0.002 | -0.011 |
| Financing Activities: | ||||||||||
| Debt Repayment
| -29.4 | -0.053 | -0.113 | -0.082 | -0.068 | -0.056 | -0.045 | 0 | 0 | -0.002 |
| Common Stock Issued
| 0.755 | 698.763 | 951.972 | 1,652.74 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | -0.041 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 |
| Other Financing Activities
| 0.001 | -697.894 | -951.002 | -1,650.877 | 0.405 | 0.36 | 0.031 | 0 | 0.038 | 0.02 |
| Financing Cash Flow
| -33.463 | 0.816 | 0.857 | 1.78 | 0.296 | 0.304 | 0.076 | 0 | 0.038 | 0.018 |
| Other Information: | ||||||||||
| Effect Of Forex Changes On Cash
| -2.673 | 0.016 | -0.036 | -0.091 | -0.003 | -0 | -0 | 0.001 | 0 | -0 |
| Net Change In Cash
| -420.443 | -0.062 | -0.138 | 0.869 | 0.058 | 0.124 | 0.004 | -0.016 | 0.024 | -0.001 |
| Cash At End Of Period
| 444.027 | 0.864 | 0.926 | 1.065 | 0.196 | 0.138 | 0.013 | 0.01 | 0.026 | 0.002 |